BRCA1 transactivates the cyclin-dependent kinase inhibitor p27Kip1

被引:49
作者
Williamson, EA
Dadmanesh, F
Koeffler, HP
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Med, Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Anat Pathol, Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
关键词
BRCA1; p27(Kip1); transcriptional regulation;
D O I
10.1038/sj.onc.1205461
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p27(Kip1) is a member of the universal cyclin-dependent kinase inhibitor family. Previously, immunochemical analysis of a series of breast cancer cell lines demonstrated a correlation between the expression of P27(Kip1) and the breast cancer susceptibility gene BRCA1. BRCA1 has a number of activities including DNA repair, growth inhibition and as a transcription factor. Here we demonstrate that BRCA1 transactivates expression of p27(Kip1). This transactivation is dependent on the presence of a functional C-terminal transactivation domain. Promoter-deletion analysis identified the presence of a putative BRCA1-responsive element located at position -615 to -511 of the p27(Kip1) promoter. These results suggest that the transcriptional regulation of p27(Kip1) by BRCA1 may be a mechanism for BRCA1- induced growth inhibition.
引用
收藏
页码:3199 / 3206
页数:8
相关论文
共 39 条
  • [1] BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair
    Abbott, DW
    Thompson, ME
    Robinson-Benion, C
    Tomlinson, G
    Jensen, RA
    Holt, JT
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) : 18808 - 18812
  • [2] BRCA1-associated growth arrest is RB-dependent
    Aprelikova, ON
    Fang, BS
    Meissner, EG
    Cotter, S
    Campbell, M
    Kuthiala, A
    Bessho, M
    Jensen, RA
    Liu, ET
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (21) : 11866 - 11871
  • [3] From BRCA1 to RAP1: A widespread BRCT module closely associated with DNA repair
    Callebaut, I
    Mornon, JP
    [J]. FEBS LETTERS, 1997, 400 (01): : 25 - 30
  • [4] Decreased levels of the cell-cycle inhibitor p27(Kip1) protein: Prognostic implications in primary breast cancer
    Catzavelos, C
    Bhatacharya, N
    Ung, YC
    Wilson, JA
    Roncari, L
    Sandhu, C
    Shaw, P
    Yeger, H
    MoravaProtzner, I
    Kapusta, L
    Franssen, E
    Pritchard, KI
    Slingerland, JM
    [J]. NATURE MEDICINE, 1997, 3 (02) : 227 - 230
  • [5] Transcriptional activation by BRCA1
    Chapman, MS
    Verma, IM
    [J]. NATURE, 1996, 382 (6593) : 678 - 679
  • [6] Germline BRCA1/2 mutations and p27Kip1 protein levels independently predict outcome after breast cancer
    Chappuis, PO
    Kapusta, L
    Bégin, LR
    Wong, N
    Brunet, JS
    Narod, SA
    Slingerland, J
    Foulkes, WD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (24) : 4045 - 4052
  • [7] Chen YM, 1999, J CELL PHYSIOL, V181, P385, DOI 10.1002/(SICI)1097-4652(199912)181:3<385::AID-JCP2>3.0.CO
  • [8] 2-4
  • [9] Ciaparrone M, 1998, CANCER RES, V58, P114
  • [10] Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma
    Cordon-Cardo, C
    Koff, A
    Drobnjak, M
    Capodieci, P
    Osman, I
    Millard, SS
    Gaudin, PB
    Fazzari, M
    Zhang, ZF
    Massague, J
    Scher, HI
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (17): : 1284 - 1291